Tarsus Pharmaceuticals, Inc. · 3 hours ago
Intern, Commercial Strategy
Irvine, California, United States
Internship
Hybrid
Intern
$26/hr - $45/hrTarsus Pharmaceuticals, Inc. is seeking a Commercial Strategy and Analytics intern to help integrate an AI LLM provider with their Tableau reporting environment. The intern will research AI providers, interview stakeholders, and present recommendations to the Commercial leadership team.
BiopharmaBiotechnologyLife Science
Responsibilities
Research available AI LLM providers that integrate with Tableau and determine pros and cons of built-in vs. custom integrations
Interview Analytics team and other relevant commercial stakeholders to understand and capture business needs and requirements
Collaborate with our internal IT team and Salesforce to understand technical requirements for integration, ensuring data privacy and protection is paramount
Present to Commercial leadership on recommendation and key findings – along with proposed plan for implementation
Uncover potential use cases for how an AI LLM could be implemented to meet the needs of the Commercial team
Qualification
Required
Current Bachelors or Masters student in communications, business, statistics, data science, or a related field
Strong interest in the pharmaceutical and life sciences industry
Problem-solving mindset, ability to successfully navigate ambiguity/complexity
Ability to synthesize complex information into actionable strategy and tactics
Advanced PowerPoint skills required
Familiarity with LLMs (ChatGPT, Gemini, etc) required
Must be a team player with strong self-awareness and excellent interpersonal skills
Benefits
Snacks and drinks
Occasional catered meals
Hybrid work environment
Lunch and learns
Development opportunities
Offsite volunteering
Company-wide social events
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Founded in 2017
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Jeffrey Farrow
Chief Financial Officer and Chief Strategy Officer
Bobak Azamian
Chairman
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase